Healthequity Inc [HQY] stock is trading at $92.78, up 0.75%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HQY shares have gain 3.46% over the last week, with a monthly amount glided 1.39%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Raymond James upgraded its rating to Strong Buy on March 25, 2025, and dropped its price target to $115. On December 04, 2024, Mizuho initiated with an Outperform rating and assigned a price target of $126 on the stock. Goldman started tracking the stock assigning a Neutral rating and suggested a price target of $108 on November 15, 2024. JMP Securities initiated its recommendation with a Mkt Outperform and recommended $101 as its price target on April 04, 2024. JP Morgan reiterated a Overweight rating for this stock on April 02, 2024, and upped its price target to $108. In a note dated January 03, 2024, Barclays initiated an Overweight rating and provided a target price of $84 on this stock.
Healthequity Inc [HQY] stock has fluctuated between $74.07 and $116.65 over the past year. Currently, Wall Street analysts expect the stock to reach $121 within the next 12 months. Healthequity Inc [NASDAQ: HQY] shares were valued at $92.78 at the most recent close of the market. An investor can expect a potential return of 30.42% based on the average HQY price forecast.
Analyzing the HQY fundamentals
Healthequity Inc [NASDAQ:HQY] reported sales of 1.27B for the trailing twelve months, which represents a growth of 8.64%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.07 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.49.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 91.37 points at the first support level, and at 89.96 for the second support level. However, for the 1st resistance point, the stock is sitting at 94.30, and for the 2nd resistance point, it is at 95.81.
Ratios To Look Out For
For context, Healthequity Inc’s Current Ratio is 4.23. Also, the Quick Ratio is 4.23, while the Cash Ratio stands at 2.61. Considering the valuation of this stock, the price to sales ratio is 6.30, the price to book ratio is 3.74 and price to earnings (TTM) ratio is 56.17.
Transactions by insiders
Recent insider trading involved Delano Ladd, Officer, that happened on Oct 06 ’25 when 977.0 shares were purchased. Officer, James M. Lucania completed a deal on Oct 06 ’25 to buy 2393.0 shares. Meanwhile, Officer Stephen Neeleman bought 1058.0 shares on Oct 06 ’25.
